跳转至内容
Merck
CN
所有图片(3)

文件

SML0534

Sigma-Aldrich

维替泊芬

≥94% (HPLC)

登录查看公司和协议定价
所有图片(3)
别名:
反式-18-乙烯基-4,4a-二氢-3,4-双（甲氧羰基）-4a，8,14,19-四甲基-23H，25H-苯并[b]卟吩-9,13-二丙酸单甲酯, 维速达尔, （4R，4aS）-rel-18-乙烯基-4,4a-二氢-3,4-双（甲氧羰基）-4a，8,14,19-四甲基-24H，26H-苯并[b]卟吩-9,13-二丙酸单甲酯
经验公式（希尔记法）:
C41H42N4O8
CAS号:
129497-78-5
分子量:
718.79
MDL编号:
MFCD11982858
UNSPSC代码:
12352200
PubChem化学物质编号:
329825538
NACRES:
NA.77

质量水平

100

检测方案

≥94% (HPLC)

形式

powder

储存条件

desiccated
protect from light

溶解性

DMSO: 2 mg/mL, clear (warmed)

储存温度

−20°C

SMILES字符串

CC(C(/C=C1[C@@]2(C)C(/C(N/1)=C/3)=CC=C(C(OC)=O)[C@H]2C(OC)=O)=N/4)=C(CCC(OC)=O)C4=C\C5=C(CCC(O)=O)C(C)=C(/C=C6C(C=C)=C(C)C3=N/6)N5.CC(C(/C=C7[C@@]8(C)C(/C(N/7)=C/9)=CC=C(C(OC)=O)[C@H]8C(OC)=O)=N/%10)=C(CCC(O)=O)C%10=C\C%11=C(CCC(OC)=O)C(C)=C(/C=C%12C(C=C)

InChI

1S/2C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)24(11-14-36(46)47)32(44-30)18-33-25(12-15-37(48)51-6)21(3)28(43-33)16-31(23)42-29;1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h2*9-10,13,16-19,38,43,45H,1,11-12,14-15H2,2-8H3,(H,46,47)/b31-16-,32-18-,34-17-,35-19-;31-16-,33-18-,34-17-,35-19-/t2*38-,41+/m00/s1

InChI key

YHNBVDZVUQFVLS-SKJZPIBWSA-N

正在寻找类似产品? 访问 产品对比指南

应用

维替泊芬已被用作光敏剂。它还可用作YAP（Yes-相关蛋白）-TEA结构域（TEAD）相互作用的抑制剂。

生化/生理作用

维替泊芬具有破坏YAP（Yes-相关蛋白）/TAZ（具有PDZ结合基序的转录共激活因子）和TEA结构域（TEAD）复合物之间的相互作用的能力。它还可降低卵巢癌细胞的活力，并几乎消除细胞迁移。因此，维替泊芬被认为是治疗卵巢癌的有效方法。
维替泊芬是一种用于光动力疗法的光敏剂，可用于消除与黄斑变性等病症相关的眼内异常血管。维替泊芬可在异常血管中积聚，当在氧气存在下被波长为693nm的非热红光刺激时，可产生高反应性的短寿命单线态氧和其他活性氧自由基，从而导致局部内皮损伤和血管阻塞。维替泊芬主要定位于线粒体中。

其他说明

光敏感

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Akihiro Yamashita et al.
Stem cells translational medicine, 10(1), 115-127 (2020-08-22)
Human induced pluripotent stem cells (hiPSCs) are a promising cell source for the creation of cartilage to treat articular cartilage damage. The molecular mechanisms that translate culture conditions to the chondrogenic differentiation of hiPSCs remain to be analyzed. To analyze
YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer.
Kuser-Abali G, et al.
Nature Communications, 6, 8126-8126 (2015)
Victor C K Lo et al.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 31(9), 1398-1405 (2013-04-30)
Photodynamic therapy (PDT) has been shown to ablate tumors within vertebral bone and yield short-term improvements in vertebral architecture and biomechanical strength, in particular when combined with bisphosphonate (BP) treatment. Longer-term outcomes of PDT combined with current treatments for skeletal
Alan F Cruess et al.
Acta ophthalmologica, 87(2), 118-132 (2008-06-26)
Photodynamic therapy (PDT) with verteporfin has been used less comprehensively in the treatment of exudative age-related macular degeneration (AMD), and specifically of choroidal neovascularization (CNV), since the advent of antiangiogenic therapies. Recently, there has been a renewed interest in PDT
Yukari Mae et al.
Molecular and clinical oncology, 13(3), 10-10 (2020-08-06)
Photodynamic therapy (PDT) induces photochemical reactions, resulting in the destruction of tumor cells via singlet (S1) oxygen production. This cellular destruction occurs specifically in tumor cells, following selective accumulation of a photosensitizer and its excitation by a specific wavelength. Verteporfin
查看所有相关文献

相关内容

DISCOVER Bioactive Small Molecules for Nitric Oxide & Cell Stress Research

DISCOVER Bioactive Small Molecules for Nitric Oxide & Cell Stress Research

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门